|
1
|
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
|
J Clin Oncol
|
2011
|
4.12
|
|
2
|
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.74
|
|
3
|
Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
|
J Neurosci
|
2010
|
1.12
|
|
4
|
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.
|
J Neurooncol
|
2013
|
0.94
|
|
5
|
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.
|
Exp Neurol
|
2011
|
0.92
|
|
6
|
Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant.
|
Leuk Lymphoma
|
2013
|
0.88
|
|
7
|
Ambient Particulate Matter Air Pollution Exposure and Mortality in the NIH-AARP Diet and Health Cohort.
|
Environ Health Perspect
|
2015
|
0.82
|
|
8
|
Mapping structurally defined guanine oxidation products along DNA duplexes: influence of local sequence context and endogenous cytosine methylation.
|
J Am Chem Soc
|
2014
|
0.81
|
|
9
|
Management of Unplanned Excision for Soft-Tissue Sarcoma With Preoperative Radiotherapy Followed by Definitive Resection.
|
Am J Clin Oncol
|
2016
|
0.80
|
|
10
|
A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients.
|
Biol Blood Marrow Transplant
|
2012
|
0.79
|
|
11
|
In regard to Yamamoto et al.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.75
|
|
12
|
Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
|
Blood Coagul Fibrinolysis
|
2014
|
0.75
|
|
13
|
Re-irradiation of the head and neck using highly conformal tomotherapy intensity-modulated radiation therapy.
|
Minn Med
|
2014
|
0.75
|